ナミキ商事株式会社 医薬品及び創薬化学品の専門商社

医薬品及び創薬化学品の専門商社

検索検索

バイオ製品Bio Products

リコンビナントタンパク質

ACROBiosystems社 プロダクトリスト:Recombinant Protein

サプライヤー
AcroBioSystems
カタログNo.
NS8-C5149
製品名称
SARS-CoV-2 (COVID-19) NSP8 Protein, His Tag
タンパク質名
NSP8
Species
SARS-CoV-2
HOST
E. coli
100ug: 112000円
お問い合わせ
1mg: 800800円
お問い合わせ

Overview

Synonyms -
Characteristics This protein carries a polyhistidine tag at the N-terminus. The protein has a calculated MW of 23.9 kDa. The protein migrates as 22-25 kDa under reducing (R) condition (SDS-PAGE).
Endotoxin Level 1.0 EU per μg
Purity 95%
Description NSP8, forms a hexadecamer with nsp7 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, may synthesize substantially longer products than oligonucleotide primers. To ultimately combat the emerging COVID-19 pandemic, it is desired to develop an effective and safe vaccine against this highly contagious disease caused by the SARS-CoV-2 coronavirus. By investigating the entire proteome of SARS-CoV-2, six proteins, including the S protein and five non-structural proteins (nsp3, 3CL-pro, and nsp8-10) were predicted to be adhesins, which are crucial to the viral adhering and host invasion. The S, nsp3, and nsp8 proteins were also predicted by Vaxign-ML to induce high protective antigenicity.
Reference -
URL https://www.acrobiosystems.com/P3173-SARS-CoV-2-%28COVID-19%29-NSP8-Protein-His-Tag.html

お問い合わせリスト(-)

お問い合わせフォーム